Revolution Medicines Corp (RVMD) Company Cash on Hand

Graphic logo of Revolution Medicines Inc (RVMD)

Revolution Medicines leverages its authority in targeted oncology to develop drugs combating the RAS pathway for patients with limited options. The cash accumulation chart confirms financial stability, where the latest parameter stands at 3.66. Efficiency is maintained through the strategic outsourcing of drug synthesis and early-stage testing to external partners, which completely mitigates operational dependency risks.

RVMD - RevMed Company Liquid Assets over the range 07/04/2022 - 11/21/2026

RevMed (RVMD) - metric breakdowns and financial figures

Fundamental valuation:RVMD revmed.com
Signature product of Revolution Medicines Inc

This indicator captures the absolute volume of liquid assets, allowing for the real-time tracking of cash reserve accumulation or burn rates. For Revolution Medicines (RVMD), this metric confirms the ability to fund high-tech laboratories and audits of partner factories, while the company's cash on hand serves as a marker of financial stability in the face of operating expenses.

Competitors of Revolution Medicines

Company Cash Volume ONC|HALO - Company Cash Reserve|Company Cash Volume AAPG (ascentage.com)|CG Oncology Inc (CGON) - Company Cash Reserve|URGN - Company Cash Funds|Bicara Bio - Company Total Cash Amount|PSNL: Company Cash Volume|Company Cash and Cash Equivalents ERAS|Company Cash on Hand DCTH|Company Cash Reserve Y-mAbs Therapeutics Inc YMAB|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds